Demant A/S (CPH:DEMANT)
243.60
+0.60 (0.25%)
Aug 14, 2025, 4:59 PM CET
Demant Revenue
Demant had revenue of 11.25B DKK in the half year ending June 30, 2025, with 5.23% growth. This brings the company's revenue in the last twelve months to 22.59B, up 2.69% year-over-year. In the year 2024, Demant had annual revenue of 22.42B with 3.79% growth.
Revenue (ttm)
22.59B
Revenue Growth
+2.69%
P/S Ratio
2.29
Revenue / Employee
1.02M
Employees
22,639
Market Cap
51.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.42B | 818.00M | 3.79% |
Dec 31, 2023 | 21.60B | 1.90B | 9.62% |
Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 311.94B |
Coloplast | 27.79B |
Genmab | 23.16B |
ALK-Abelló | 5.71B |
H. Lundbeck | 22.95B |
Ambu A/S | 5.83B |
Zealand Pharma | 55.69M |
Bavarian Nordic | 6.23B |